Big companies like Monsanto-Bayer are preparing large-scale corporate colonization of a GMO herb
The expanding cannabis industry is attracting new investors and companies looking to join the green rush. Unfortunately, it is also attracting GMO producers, Monsanto and Bayer, who are interested in a genetically modified cannabis industry. In 2016, Scott's Miracle-Gro CEO Jim Hagedorn expressed his desire to buy out the distribution business and put up $ 500 million of his own cash to create a GMO herb. This mega corporation movement is called Big Cannabis, which alludes to what Big Pharma is ...
A dangerous monopoly
La recent merger of Monsanto and Bayer and the growing interest in our favorite herb is a major concern for cannabis advocates. Last year, Monsanto patented the first genetically modified strain of cannabis. In addition, Scott's Miracle-Gro (manufacturer of pesticides and herbicides), whose CEO wants to acquire the entire industry, is affiliated with Monsanto, while Bayer is connected to the British company GW Pharmaceuticals ... which sells Sativex, a spray treatment for symptoms of multiple sclerosis.
A possible takeover of the marijuana industry by this monopoly means that genetically modified (or synthetic) marijuana could become the norm. Monsanto's recent drive to “educate” European farmers in modernized agriculture (GMOs) is seen as an attempt to include GMO strains in everyday life… Given this, and the fact that Monsanto and Bayer currently share Trade secrets regarding the production of genetically modified marijuana, they seem to pave the way for the large-scale corporate colonization of cannabis.
Billionaire George Soros, who owns 630 shares of Monsanto, has set up millions at home and abroad to legalize cannabis. But the potential motives for these investments could mean problems on the horizon for the cannabis industry.
The "Big Cannabis"
Pushing for legalization is a noble cause for many of us. But increased legalization could continue to open counters and massively to this kind of companies. So industry analysts call this environment "Big Cannabis", in reference to the rich industry that is Big Pharma. James Adamson, president of Medical Marijuana Technologies, says much of the leverage to make cannabis legal can be heavily influenced by this “Big Cannabis” monopoly.
There is currently no way to control the production of marijuana and the quality of the strains. A genetically modified strain produced by a company with Monsanto powers would undoubtedly offer massive help to pro-legalization activists ... And especially in certain spheres of government and especially in the business world ...
As it stands, the federal illegal status of marijuana may be the only thing standing between Monsanto, Bayer and the cannabis industry. Their activities remain limited to the 29 states that have legalized or decriminalized marijuana; however, Drug Policy Alliance law scholar Edmund Groensch believes that a huge push from big business players may be the only way marijuana could become. legal at the federal level.
Federal trust for Big Cannabis
Currently, federal law criminalizes derivatives of marijuana and hemp. And all because the public opinion is still against this federal law and its classifications like Schedule 1… A major player like Monsanto could unfortunately bring confidence within the government and towards the investors. The cannabis market would grow richly, Big Cannabis… Because Monsanto would concede a large part of its exploitable land and its commercial products.
Federal cannabis approval sounds like a dream… But if companies like Monsanto and Bayer monopolize the market, we could end up with genetically modified (GMO) weed. A less effective and potentially harmful weed for the future ...